Shares of Aurobindo Pharma Ltd ended at ₹1,570.90, up by ₹10.35, or 0.66%, on the BSE. Previous Post SEBI asks depositories to put in place operational framework to implement buyback rules from Aug 1 Next Post Aditya Birla Capital invests ₹124 crore in health insurance arm to meet solvency norms Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment